Target intelligence / Profile preview

CIDEC pseudogene 2 (CIDECP2)

Target
CIDECP2
Molecular classification
Other (Pseudogene)
01

Overview

CIDEC pseudogene 2 (CIDECP2) is a genomic sequence highly homologous to the functional gene CIDEC (cell death-inducing DNA fragmentation factor-like effector C), but it is classified as a pseudogene and not believed to encode a functional protein. Pseudogenes like CIDECP2 have historically been considered genomic relics without function, though some pseudogenes may exert regulatory effects on gene expression of their parental genes. However, CIDECP2 specifically has no established biological function, disease association, or role as a therapeutic target. It is most relevant as a point of comparison in computational analyses involving pseudogene expression, where pseudogenes as a class may help stratify cancer subtypes or serve as non-coding RNA biomarkers.

Other names
CIDECP2CIDEC pseudogene on chromosome 3
02

Mechanism of action

None

03

Biological functions

None established for CIDECP2 itself; pseudogenes do not typically encode functional proteins, though some can regulate parental gene expression or have non-coding RNA rolesParent gene (CIDEC) functions in apoptosis and lipid metabolism, but CIDECP2 does not share established functional annotation
04

Disease associations

No direct disease role is known for CIDECP2.Expression profiles of various pseudogenes (not CIDECP2 specifically) have been linked to cancer subtyping and prognosis in large-scale analyses, as non-coding transcript markers
05

Safety considerations

None
06

Interacting drugs

None
07

Biomarkers

Pseudogene expression signatures have value as biomarkers for certain cancer subtypes, but not specifically for CIDECP2

Beyond the preview

Go deeper on CIDEC pseudogene 2 (CIDECP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CIDEC pseudogene 2 (CIDECP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call